Socioeconomic Status Tied to New Diagnosis of Hidradenitis Suppurativa
WEDNESDAY, May 14, 2025 -- For dermatology patients, neighborhood-level socioeconomic status (nSES) is associated with a new diagnosis of hidradenitis suppurativa (HS), according to a study published online May 14 in JAMA Dermatology.
Aileen Y. Chang, M.D., from the University of California San Francisco School of Medicine, and colleagues conducted a cross-sectional study of patients from dermatology clinics in the University of California San Francisco health system between Aug. 1, 2019, and May 31, 2024, to examine the association of nSES with new HS diagnoses among dermatology patients. The researchers assigned nSES quintiles based on the distribution of nSES index values among census tracts in the San Francisco Bay Area, from quintile 1 (lowest nSES census tracts) to quintile 5 (highest nSES census tracts).
The analyses included 65,766 patients, of whom 0.7 percent had a new HS diagnosis. The researchers found that after adjusting for age, sex, and race and ethnicity, lower-SES neighborhoods had greater odds of a new HS diagnosis (odds ratios for quintile 1, 2, 3, and 4 versus 5: 3.32, 2.25, 1.97, and 1.44, respectively). Among patients residing in lower-SES neighborhoods, greater odds of a new HS diagnosis were seen in race-stratified analyses, although the pattern did not reach statistical significance in all racial and ethnic groups.
"This finding supports the hypothesis that neighborhood-level factors may influence the development of HS," the authors write.
Several authors disclosed ties to the biopharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Evidence Insufficient to Determine Benefits of Multicancer Screening Tests
THURSDAY, Sept. 18, 2025 -- No controlled studies report benefits of screening with multicancer detection (MCD) tests, according to a study published online Sept. 16 in the Annals...
Nonadherence to Cervical Cancer Screening Increased After COVID-19 Pandemic
THURSDAY, Sept. 18, 2025 -- Nonadherence to cervical cancer screening in the United States increased after the COVID-19 pandemic, according to a study published online Sept. 10...
Guidance Issued for Creation of pAVFs for Hemodialysis Access
THURSDAY, Sept. 18, 2025 -- In a guidance document issued by the Society of Interventional Radiology Practice and published online Sept. 9 in the Journal of Vascular and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.